Idioma:

Mid-Regional Proadrenomedullin in COVID-19-May It Act as a Predictor of Prolonged Cardiovascular Complications?

Pietraszko, Paulina ; Zorawski, Marcin ; Bielecka, Emilia ; Sielatycki, Piotr ; Zbroch, Edyta

International journal of molecular sciences, 2023-12, Vol.24 (23), p.16821 [Periódico revisado por pares]

Switzerland: MDPI AG

Texto completo disponível

Citações Citado por

Enviar para

Título:
Mid-Regional Proadrenomedullin in COVID-19-May It Act as a Predictor of Prolonged Cardiovascular Complications?
Autor: Pietraszko, Paulina ; Zorawski, Marcin ; Bielecka, Emilia ; Sielatycki, Piotr ; Zbroch, Edyta
Assuntos: Adrenomedullin ; Biomarkers ; cardiovascular complications ; Cardiovascular disease ; cardiovascular diseases ; Cardiovascular Diseases - etiology ; Cardiovascular system ; Complications and side effects ; Coronaviruses ; COVID-19 ; COVID-19 - complications ; Cytokines ; Diabetes ; Global economy ; Heart failure ; Humans ; Hypertension ; Infections ; Kinases ; long-COVID-19 ; mid-regional proadrenomedullin ; Mortality ; Plasma ; Post-Acute COVID-19 Syndrome ; Prognosis ; Proteins ; Risk assessment ; SARS-CoV-2 ; Smooth muscle
É parte de: International journal of molecular sciences, 2023-12, Vol.24 (23), p.16821
Notas: ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-3
content type line 23
ObjectType-Review-1
Descrição: The rising prevalence of cardiovascular disease (CVD) and the impact of the SARS-CoV-2 pandemic have both led to increased mortality rates, affecting public health and the global economy. Therefore, it is essential to find accessible, non-invasive prognostic markers capable of identifying patients at high risk. One encouraging avenue of exploration is the potential of mid-regional proadrenomedullin (MR-proADM) as a biomarker in various health conditions, especially in the context of CVD and COVID-19. MR-proADM presents the ability to predict mortality, heart failure, and adverse outcomes in CVD, offering promise for improved risk assessment and treatment strategies. On the other hand, an elevated MR-proADM level is associated with disease severity and cytokine storms in patients with COVID-19, making it a predictive indicator for intensive care unit admissions and mortality rates. Moreover, MR-proADM may have relevance in long COVID, aiding in the risk assessment, triage, and monitoring of individuals at increased risk of developing prolonged cardiac issues. Our review explores the potential of MR-proADM as a predictor of enduring cardiovascular complications following COVID-19 infection.
Editor: Switzerland: MDPI AG
Idioma: Inglês

Links

View this record in MEDLINE/PubMed

Voltar para lista de resultados

Realização: Logos de Redes Sociais:

Mid-Regional Proadrenomedullin in COVID-19-May It Act as a Predictor of Prolonged Cardiovascular Complications?

Pietraszko, Paulina ; Zorawski, Marcin ; Bielecka, Emilia ; Sielatycki, Piotr ; Zbroch, Edyta

Switzerland: MDPI AG

Buscando em bases de dados remotas. Favor aguardar.